Q-Line Biotech Reports H1 FY27 Results with 10.0% EBITDA Growth
Q-Line Biotech Ltd · Investor Presentation · 13 Nov 2026, 4:52 pm
Q-Line Biotech Reports H1 FY27 Results with 10.0% EBITDA Growth Q-Line Biotech reported a 5.8% YoY rise in H1 FY27 revenue to ₹152 Cr, while EBITDA increased 10.0% YoY to ₹40 Cr, expanding margins to 26.0%. PAT fell 8.1% YoY to ₹20 Cr, impacted by higher depreciation from the newly capitalized Unit 4 facility and base-year tax write-backs. Reagent sales rose 19.23%, whereas instrument revenue dropped 29.71% due to government supply execution delays. The company plans to operationalize Unit 4 fully in H2 FY27 and acquire a 70% stake in Heidelco Medicore.
Original exchange filing (PDF)
More announcements from Q-Line Biotech Ltd
- Q-Line Biotech Limited has informed the Exchange regarding 'Submission of audio recording of Earnings Conference Call-13.11.2026'. · 15 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about General Updates · 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange regarding a press release dated November 12, 2026, titled "PRESS RELEASE ON FINANCIAL RESULTS 30 SEPTEMBER 2026.". · 13 Nov 2026
- Q-Line Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange regarding 'Board comments on fine levied by the Exchange'. · 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Schedule of meet · 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 12 Nov 2026
- Q-Line Biotech Limited has informed the Exchange regarding 'Clarification-'.that due to an inadvertent clerical error, the time in the subject line of the filing was mentioned as 3:00 P.M. instead of 4:15 P.M.We hereby clarify that the correct time of the Board Meeting is 4:15 P.M., as mentioned in the Board Meeting notice. The incorrect reference to 3:00 P.M. in the subject line may kindly be treated as an inadvertent error.We regret the inconvenience caused and request you to take the above cl · 06 Nov 2026
